(-0.07%) 5 465.31 points
(-0.07%) 39 084 points
(0.18%) 17 750 points
(-0.58%) $80.36
(-4.32%) $2.64
(-0.87%) $2 310.60
(-0.05%) $28.86
(2.30%) $1 009.10
(0.30%) $0.936
(0.73%) $10.68
(0.48%) $0.792
(-0.28%) $87.25
33.33% $ 0.000800
Live Chart Being Loaded With Signals
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore...
Stats | |
---|---|
Today's Volume | 8 000 |
Average Volume | 0 |
Market Cap | 899 081 |
EPS | $-0.0932 ( Q3 | 2023-11-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
-0.000132 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-29 | Denny George P Iii | Buy | 3 913 526 | Warrants to Purchase Common Stock |
2023-12-29 | Denny George P Iii | Buy | 0 | 12.0% Senior Secured Convertible Notes |
2023-12-27 | Denny George P Iii | Buy | 0 | Common Stock |
2023-01-04 | Denny George P Iii | Buy | 405 405 | Warrants to Purchase Common Stock |
2023-09-11 | Denny George P Iii | Buy | 337 408 | Warrants to Purchase Common Stock |
INSIDER POWER |
---|
85.96 |
Last 87 transactions |
Buy: 59 308 949 | Sell: 6 106 091 |
Comera Life Sciences Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Comera Life Sciences Financials
Annual | 2022 |
Revenue: | $633 102 |
Gross Profit: | $422 712 (66.77 %) |
EPS: | $-2.30 |
FY | 2022 |
Revenue: | $633 102 |
Gross Profit: | $422 712 (66.77 %) |
EPS: | $-2.30 |
FY | 2021 |
Revenue: | $319 832 |
Gross Profit: | $158 824 (49.66 %) |
EPS: | $0 |
FY | 2020 |
Revenue: | $442 919 |
Gross Profit: | $338 512 (76.43 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Comera Life Sciences
Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform, SQore. Its SQore platform is designed to enable the conversion of intravenous (IV) biologics to subcutaneous (SQ) versions. The company is advancing its primary product programs, CLS-001, a preclinical stage biobetter for Crohn\'s and Ulcerative Colitis disease, and CLS-002, a preclinical stage biobetter for various oncology indications. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators